Knight Therapeutics, Inc. (GUD.TO)
9.76
+0.01
(+0.10%)
CAD |
TSX |
Aug 26, 16:00
Knight Therapeutics Debt to Equity Ratio : 0.0429 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0429 |
| March 31, 2026 | 0.0886 |
| December 31, 2025 | 0.1015 |
| September 30, 2025 | 0.1386 |
| June 30, 2025 | 0.1373 |
| March 31, 2025 | 0.0678 |
| December 31, 2024 | 0.0622 |
| September 30, 2024 | 0.0752 |
| June 30, 2024 | 0.0762 |
| March 31, 2024 | 0.092 |
| December 31, 2023 | 0.0925 |
| September 30, 2023 | 0.1007 |
| June 30, 2023 | 0.0981 |
| March 31, 2023 | 0.1009 |
| December 31, 2022 | 0.0941 |
| September 30, 2022 | 0.0457 |
| June 30, 2022 | 0.0461 |
| March 31, 2022 | 0.0564 |
| December 31, 2021 | 0.0486 |
| September 30, 2021 | 0.0464 |
| June 30, 2021 | 0.0448 |
| March 31, 2021 | 0.0505 |
| December 31, 2020 | 0.0634 |
| September 30, 2020 | 0.0542 |
| June 30, 2020 | 0.0648 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0825 |
| December 31, 2019 | 0.0767 |
| September 30, 2019 | 0.001 |
| June 30, 2019 | 0.001 |
| March 31, 2019 | 0.001 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.0299 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| HLS Therapeutics, Inc. | 0.7586 |
| Bausch Health Cos., Inc. | -11.73 |
| Cipher Pharmaceuticals, Inc. | 0.0027 |
| BioSyent, Inc. | 0.0685 |
| Revive Therapeutics Ltd. | -0.0176 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.045B |
| Total Liabilities (Quarterly) | 246.25M |
| Shareholders Equity (Quarterly) | 798.59M |
| Current Ratio | 2.280 |
| Net Debt Paydown Yield | 0.41% |